Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

ClinicalTrials.gov ID: NCT00226421

Public ClinicalTrials.gov record NCT00226421. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 4:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Titration Followed by a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Oxymorphone Extended Release Tablets in Opioid-Experienced Patients With Chronic Low Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the analgesic efficacy and safety of oxymorphone extended release in opioid-experienced patients with chronic low back pain.

Study identification

NCT ID
NCT00226421
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
120 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Not listed
Completion
Aug 2005 (Type not available)
Last update posted
Jan 2, 2024

2004 – 2005

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
Southern Drug Research Hueytown Alabama 35023 —
Phoenix Center for Clinical Research Phoenix Arizona 85015 —
Arizona Research Phoenix Arizona 85023 —
Express Care Clinical Research Colorado Springs Colorado 80909 —
Glasgow Family Practice Newark Delaware 19702 —
Radiant Research Daytona Beach Florida 32114 —
University Clinical Research DeLand Florida 32720 —
LCFP Inc. Fort Myers Florida 33907 —
Century Clinical Research Holly Hill Florida 32117 —
Ocala Rheumatology Research Center Ocala Florida 34474 —
The Arthritis Center Palm Harbor Florida 34684 —
Radiant Research Pinellas Park Florida 33781 —
Park Place Therapeutic Center Plantation Florida 33324 —
Comprehensive Neurology Specialists Atlanta Georgia 30338 —
Comprehensive Neuroscience Atlanta Georgia 30338 —
Pain Specialists of Greater Chicago Burr Ridge Illinois 60527 —
Mid-America Physiatrists Overland Park Kansas 66211 —
Research Medical Center Kansas City Missouri 64132 —
Radiant Research St Louis Missouri 63141 —
Comprehensive Clinical Research Berlin New Jersey 08009 —
Piedmont Anesthesia Winston-Salem North Carolina 27103 —
Health Research Institute Oklahoma City Oklahoma 73109 —
Pain Consultants of Oregon Eugene Oregon 97401 —
Keystone Medical Research Altoona Pennsylvania 16602 —
Perkiomen Valley Family Practice Collegeville Pennsylvania 19426 —
Feasterville Family Health Center Feasterville Pennsylvania 19053 —
Fleetwood Clinical Research Fleetwood Pennsylvania 19522 —
Paragon Clinical Research Cranston Rhode Island 02920 —
Waccamaw Pain Management Murrells Inlet South Carolina 29576 —
KRK Medical Research Richardson Texas 75080 —
Jean Brown Research Salt Lake City Utah 84124 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00226421, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2024 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00226421 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →